Nova Leap HealthNVLPF +18.18%50 Graham Number is $0.06 as of Mar. 2026, which is 98% below its 10-year median of 3.86. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.22 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 369 Healthcare Providers & Services companies, Nova Leap Health ranks worse than 86.18% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
As of today (2026-07-07), the stock price of Nova Leap Health is $0.2913. Nova Leap Health's graham number for the quarter that ended in Mar. 2026 was $0.06. Therefore, Nova Leap Health's Price to Graham Number ratio for today is 4.82.
The historical rank and industry rank for Nova Leap Health's Graham Number or its related term are showing as below:
NVLPF'
s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.49 Med: 3.86 Max: 6.75
Current: 4.86
During the past 10 years, the highest Price to Graham Number ratio of Nova Leap Health was 6.75. The lowest was 1.49. And the median was 3.86.
NVLPF's Price-to-Graham-Number is ranked worse than 86.18% of 369
companies
in the Healthcare Providers & Services industry
Industry Median: 1.66
vs NVLPF: 4.86
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
Nova Leap Health (OTCPK:NVLPF) Graham Number Explanation
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
Nova Leap Health's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Mar. 2026 )
=
0.2913
/
0.06
=
4.82
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
Nova Leap Health Graham Number Related Terms
Nova Leap Health Graham Number Historical Data
* Premium members only.
The historical data trend for Nova Leap Health's Graham Number can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Nova Leap Health's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Leap Health Price-to-Graham-Number vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where Nova Leap Health's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nova Leap Health (NVLPF) has a Graham Number of $0.06 as of Mar. 2026. The Graham Number values a company based on its per-share earnings and book value. View historical data on Nova Leap Health and its competitors. This is 98% below median its historical median of 3.86. Over the past decade, Nova Leap Health's Graham Number has ranged from 1.49 to 6.75. According to the industry distribution chart, Nova Leap Health ranks #318 out of 369 companies in the Healthcare Providers & Services industry, placing it in the top 86.2%.
Is Nova Leap Health's Graham Number too high?
Nova Leap Health's current Graham Number of $0.06 is 98% below median its 10-year median of 3.86. Over the past 10 years, this metric has ranged from a low of 1.49 to a high of 6.75. The Healthcare Providers & Services industry median Graham Number is 1.66. Nova Leap Health's value of $0.06 is 96.4% below this industry median. Based on the distribution chart, Nova Leap Health ranks #318 out of 369 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's Graham Number compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nova Leap Health ranks #318 out of 369 companies for Graham Number. This places Nova Leap Health in the lower half of its industry. The industry median Graham Number is 1.66. Nova Leap Health's value of $0.06 is 96.4% below this benchmark. Historically, Nova Leap Health's own Graham Number has ranged from 1.49 to 6.75 over the past decade. While the company's 10-year median is 3.86 vs. the industry median of 1.66, Nova Leap Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Healthcare Providers & Services company?
The median Graham Number among Healthcare Providers & Services companies is 1.66, based on 369 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nova Leap Health's current Graham Number of $0.06 is 96.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Nova Leap Health and its competitors. For the Healthcare Providers & Services industry, the median Graham Number is 1.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova Leap Health's current Graham Number is $0.06, which is 98% below median its own 10-year median of 3.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.22, compared to a current price of $0.29 — trading 32.4% above its estimated fair value. The current Graham Number is $0.06, which is 98% below median its 10-year median of 3.86 and 96.4% below the Healthcare Providers & Services industry median of 1.66. Nova Leap Health's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current Graham Number is $0.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nova Leap Health (NVLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued.
The current stock price of $0.29 is trading 32.4% above its estimated GF Value™ of $0.22.
GuruFocus considers Nova Leap Health to be Modestly Overvalued.
Key valuation signals for NVLPF:
Graham Number: $0.06 (98% below median its 10-year median of 3.86)
GF Value™: $0.22 vs. price of $0.29 (32.4% above fair value)
Industry Position: 96.4% below the Healthcare Providers & Services median (#318 of 369)
No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score
Get the complete analysis for NVLPF
Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVLPF has been successfully added to your 
